ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

FDA Discloses Avastin Regulatory History.

December 14, 2007

In Brief: Clark, Hutchinson Gain New Honors; Nominations Open For Bristol-Myers Award; NIH Appointments

July 1, 1983

Evidence Links Anemia Drugs With Leukemic Transformation

December 28, 2007

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975